Approval · Notice of Compliance 9309 · 2008
THYMOGLOBULIN: Notice of Compliance 9309
Issued January 22, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9309
- Date
- January 22, 2008
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Immunosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYMOGLOBULIN | Not yet assigned | — |
Medicinal ingredients
- ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG per VIAL